• 제목/요약/키워드: Variance ratio test

검색결과 202건 처리시간 0.029초

모빅캡슐(멜록시캄 7.5mg)에 대한 멜록시펜캡슐의 생물학적 동등성 (Bioequivalence of MeloxifenTM Capsule to MobicTM Capsule(Meloxicam 7.5 mg))

  • 이진성;탁성권;서지형;강종민;류주희;임성빈;홍승재;이경태
    • Journal of Pharmaceutical Investigation
    • /
    • 제39권6호
    • /
    • pp.457-463
    • /
    • 2009
  • The purpose of the present study was to evaluate the bioequivalence of meloxicam capsule, $Mobic^{TM}$ capsule( Boehringer Ingelheim Ltd., Korea) as a reference drug and $Meloxifen^{TM}$ capsule (Kukje Pharma Ind. Co., Ltd., Korea) as a test drug, according to the guidelines of Korea Food and Drug Administration(KFDA). Thirty two healthy male Korean volunteers received capsule containing meloxicam 7.5 mg in a $2{\times}2$ crossover study. There was a one-week above washout period between the doses. Plasma concentrations of meloxicam were monitored for over a period of 72 hr after administration by using a high performance liquid chromatography-tandem mass spectrometer(LC-MS/MS). $AUC_t$(the area under the plasma concentration-time curve from time zero to 72 hr), $C_{max}$(maximum plasma drug concentration) and $T_{max}$(time to reach $C_{max}$) were complied from the plasma concentration-time data. Analysis of variance(ANOVA) test was utilized for the statistical analysis of the parameters using logarithmically transformed $AUC_t$ and $C_{max}$. The 90% confidence intervals of the $AUC_t$ ratio and the $C_{max}$ ratio for $Meloxifen^{TM}/Mobic^{TM}$ were log 0.8605-log 0.9847 and log 0.9765-log 1.1503, respectively. These values were within the acceptable bioequivalence intervals of log 0.80-log 1.25, recommended by KFDA. In all of these results, we concluded that $Meloxifen^{TM}$ capsule was bioequivalent to $Mobic^{TM}$ capsule, based on the rate and extent of absorption.

스카드 정(말레인산암로디핀 6.42 mg)에 대한 에이핀 정의 생물학적 동등성 (Bioequivalence of A-PINE Tablet to SKAD Tablet (Amlodipine Maleate 6.42 mg))

  • 김성수;박완수;이헌우;서지형;김용원;조성희;류재환;이경태
    • Journal of Pharmaceutical Investigation
    • /
    • 제36권1호
    • /
    • pp.59-65
    • /
    • 2006
  • The purpose of this study was to evaluate the bioequivalence of two amlodipine maleate tablets, SKAD tablet (SK Pharma. Co., Ltd., Seoul, Korea, reference drug) and A-PINE tablet (Daewon Pharm. Co., Ltd., Seoul, Korea, test drug), according to the guidelines of Korea Food and Drug Administration (KFDA). Twenty-four healthy male volunteers, $22.79\;{\pm}\;1.86$ years in age and $70.08\;{\pm}\;8.68$ kg in body weight, were divided into two groups and a randomized $2\;{\time}\;2$ crossover study was employed. After a tablet containing 6.42 mg of amlodipine maleate was orally administrated, blood was taken at predetermined time intervals over a period of 144 hr and concentrations of amlodipine in plasma were monitored using LC-MS/MS. Pharmacokinetic parameters such as $AUC_t$ (the area under the plasma concentration-time curve from time zero to 144 hr), $C_{max}$ (maximum plasma drug concentration) and $T_{max}$ (time to reach $C_{max}$) were calculated and analysis of variance (ANOVA) test was utilized for the statistical analysis of the parameters using logarithmically transformed $AUC_t$ and $C_{max}$, and untransformed $T_{max}$. No significant sequence effect was found for all of the bioavailability parameters indicating that the crossover design was properly performed. The 90% confidence intervals of the $AUC_t$ ratio and the $C_{max}$ ratio for A-PINE/SKAD were $log\;0.9429{\sim}log \;1.1476$ and $log\;0.9l46{\sim}log\;1.1488$, respectively. Since these values were within the acceptable bioequivalence intervals of $log\;0.80{\sim}log\;1.25$, recommended by KFDA, it was concluded that A-PINE tablet was bioequivalent to SKAD tablet, in terms of both rate and extent of absorption.

리피토정® (아토르바스타틴 20 mg)에 대한 아토르바정®의 생물학적동등성 (Bioequivalence of Atorva Tablet® to Lipitor Tablet® (Atorvastatin 20 mg))

  • 임현균;이태호;이재현;염정록;송진호;한상범
    • Journal of Pharmaceutical Investigation
    • /
    • 제38권2호
    • /
    • pp.135-142
    • /
    • 2008
  • The present study describes the evaluation of the bioequivalence of two atorvastatin tablets, Lipitor $Tablet^{(R)}$ (Pfizer, reference drug) and Atorva $Tablet^{(R)}$ (Yuhan, test drug), according to the guidelines of Korea Food and Drug Administration (KFDA). Forty-nine healthy male Korean volunteers received each medicine at the atorvastatin dose of 40 mg in a $2{\times}2$ crossover study with a two weeks washout interval. After drug administration, serial blood samples were collected at a specific time interval from 0-48 hours. The plasma atorvastatin concentrations were monitored by an high performance liquid chromatography -tandem mass spectrometer (LC-MS/MS) employing electrospray ionization technique and operating in multiple reaction monitoring (MRM) and positive ion mode. The total chromatographic run time was 4.5 min and calibration curves were linear over the concentration range of 0.1-100 ng/mL for atorvastatin. The method was validated for selectivity, sensitivity, linearity, accuracy and precision. $AUC_t$ (the area under the plasma concentration-time curve from time zero to 48hr) was calculated by the linear log trapezoidal rule method. $C_{max}$ (maximum plasma drug concentration) and $T_{max}$ (time to reach $C_{max}$) were complied trom the plasma concentration-time data. Analysis of variance was carried out using logarithmically transformed $AUC_t$ and $C_{max}$. No significant sequence effect was found for all of the bioavailability parameters indicating that the crossover design was properly performed. The 90% confidence intervals of the $AUC_t$ ratio and the $C_{max}$ ratio for Atorva $Tablet^{(R)}$ / Lipitor $Tablet^{(R)}$ were ${\log}\;0.9413{\sim}{\log}\;1.0179$ and ${\log}\;0.831{\sim}{\log}\;1.0569$, respectively. These values were within the acceptable bioequivalence intervals of ${\log}\;0.8{\sim}{\log}\;1.25$. Based on these statistical considerations, it was concluded that the test drug, Atorva $Tablet^{(R)}$ was bioequivalent to the reference drug, Lipitor $Tablet^{(R)}$.

자궁적출술을 받은 부인과 자궁적출술을 받지 않은 부인의 성생활 만족 요인 분석 (Factors Influencing Sexual Satisfaction in Women who have had a Hysterectomy : A comparative group study)

  • 장순복
    • 대한간호학회지
    • /
    • 제20권3호
    • /
    • pp.357-367
    • /
    • 1990
  • This descriptive study was done to identify factors influencing sexual satisfaction in women who had had a hysterectomy and to compare these with women who had not had a hysterectomy. The purpose was to contribute theoretical understanding on which to base nursing care planning. One group of subjects were 156 women who had had a hysterectomy, between one and 18 months post surgery, living with their spouse, having no complications, and menstruating before surgery. The other group of subjects were 282 healthy women who were living with their husbands and menstruating. The study tool consisted of 108 items including item concerning personal characteristics, characteristics related to the hysterectomy, husband's support, body image, emotions, attitude toward the sexual relationship, knowledge of sexuality, sexual behavior, and sexual satisfaction. Sexual satisfaction was measured by a tool based on Derogatis Sexual Function Inventory. The range of the internal level of the study tool was from. 5208 to .9462. Data collection was done during the period from June 20 to Aug.20, 1989. The same questionnaire was used of data collection for both groups, but a mail survey method was used for the women who had had a hysterectomy, and an interview method was used for the women who had not had a hysterectomy. Data analysis was done using frequency, ratio, mean and S.D. for the characterstics of the subjects and level of sexual satisfaction. t - test or ANOVA was used for the differences between the groups with regard to the general and hysterectomy related characteristics. The relationship between the score for sex life related factors and the level of sexual satisfaction was analyzed using the Pearson Correlation, and the influencing factors on sexual satisfaction were analyzed by stepwise multiple regression. The results of this study were as follows ; 1. Mean age and income level were the only general characteristics for the two groups that were significantly different. The mean age, and income level of the group who had had a hysterectomy were 45years, and 1,150,000 won respectively, and for those who had not had a hysterectomy, 41 years and 999,000 won. 2. There was no statistical difference of the sexual satisfaction score between the two groups. 3. There was differences in the factors influencing sexual satisfaction between the two groups. Factors influencing sexual satisfaction for the group who had had a hysterectomy were husband's support (R=.5793, P=.000) and the women's Knowledge of sexuality(R=.6670, P=.000) (total variance : 33.56). On the other hand, emotional status(R=.4294, P=.000), sexual behavior(R=.4294, P=.000), husband's support(R=.5274, P=.000) and attitude towards sexual relations (R=.5412, P=.000) (total variance : 54.12) were the factors influencing sexual satisfaction in the group who had not had a hysterectomy. Since husband's support and sexuality knowledge were identified as factors influencing sexual satisfaction of women who have had a hysterectomy, it can be concluded that, before a woman who has had a hysterectomy is discharged from hospital, nurses should include strategies in the nursing care plan that will promote husband's support and the women's knowledge of sexuality.

  • PDF

제주 곶자왈숲 삼림욕 후에 심박동변이에 미친 영향 (Effects of Heart Rate Variability after Visiting the Gotjawal Forest in Jeju)

  • 신방식;이형환;이근광
    • 한국자연치유학회지
    • /
    • 제7권1호
    • /
    • pp.1-9
    • /
    • 2018
  • 제주 곶자왈 삼림욕 후 혈관연령타입, 혈관연령지수, 심박세기, 혈관탄성도, 심장의 잔혈량 및 평균맥박의 비율 변화를 조사하기 위하여 대조군은 14명과 실험군은 49명을 대상으로 손끝의 맥파 측정기로 측정하여 변화를 통계적으로 분석 연구하는 것이 목적이었다. 연구결과에서는 혈관연령타입, 혈관연령지수, 심박세기(b/a 비율), 심장의 잔혈량(d/a 비율), 평균맥박의 비율의 변화는 대조군은 사전·사후의 평균치 차이는 유의성이 없었으나, 실험군에서는 유의성이 있었으며(p<.011), 사후의 분산분석에서는 그룹 내 및 간에서도 유의한 차이를 보였다(p<.011). 혈관탄성도(c/a 비율)변화는 대조군과 실험군은 사전 사후의 평균치 차이는 유의성이 없었으며, 사후의 평균 측정치의 분산분석에서는 그룹 내에서는 유의한 차이가 있었으나, 그룹 간에서는 유의성이 없었다. 평균맥박의 변화는 그룹 내에서는 유의성이 없었으나, 그룹 간에는 유의성이 있었다. 결론적으로 제주 곶자왈숲에서 2시간 이상의 삼림욕 후에는 심박동변이(HRV)가 유의성이 높게 나타나서 b/a, c/a, d/a, e/a 비율 변이가 HRV의 변화 측정에 유용한 도구라 생각하며, 삼림욕이 심혈관의 건강 유지에 우수한 자연요법이라 판단한다.

  • PDF

혁신형 중소기업의 재무적 제약과 배당스무딩간의 관계 (The Relations between Financial Constraints and Dividend Smoothing of Innovative Small and Medium Sized Enterprises)

  • 신민식;김수은
    • 중소기업연구
    • /
    • 제31권4호
    • /
    • pp.67-93
    • /
    • 2009
  • 본 연구는 1999년 1월 1일부터 2007년 12월 31일까지 한국거래소의 유가증권시장과 코스닥시장에 상장된 혁신형 중소기업을 대상으로 재무적 제약과 배당스무딩간의 관계를 실증분석 하였으며, 주요한 분석결과는 다음과 같다. 기업들은 목표 배당성향을 가지고 있으며, 실제 배당성향이 목표 배당성향에서 이탈하면 다시 배당지급을 부분적으로 조정한다. 배당조정속도는 Lintner(1956)의 배당조정모형의 핵심변수인 전기 주당배당과 당기 주당이익을 사용하여 거의 대부분 측정할 수 있으며, 잔여배당이론과 그 이후에 등장한 배당신호이론, 대리인이론, 케이터링 이론 및 거래비용이론에 관한 대용변수들은 배당조정속도에 부분적으로 영향을 미친다. 그리고 전기 주당배당은 당기 주당이익보다 배당조정속도에 더 큰 영향을 미치는데, 이는 기업들이 특별한 이유가 없는 한 전기 주당배당 수준을 장기적으로 유지하는 안정적인 배당정책을 선호한다는 증거가 된다. 혁신형 중소기업은 비혁신형 중소기업보다 배당조정속도가 더 빠르다. 혁신형 중소기업은 R&D 투자에 따른 미래의 성장성과 수익성을 담보로 하여 장기적으로 안정적인 배당정책을 유지할 수 있다. 다시 말해, 혁신형 중소기업은 배당지급이 목표 배당성향에서 이탈하더라도, R&D 투자에 따른 미래의 성장성과 수익성을 담보로 하여 목표 배당성향을 향하여 배당지급을 신속하게 조정하여 배당스무딩을 효과적으로 달성할 수 있다. 그리고 혁신형 중소기업 중에서도 재무적 비제약 기업은 재무적 제약 기업보다 배당조정속도가 더 빠르다. 이는 재무적 비제약 기업일수록 자본시장을 통한 외부 자금조달이 용이하기 때문에 주당배당을 신속하게 조정한다는 증거가 된다. 따라서 자본시장 접근성이 용이하여 재무적 제약을 적게 받는 기업일수록 외부 자금조달이 용이하기 때문에 배당지급을 더 신속하게 조정함으로써 배당스무딩을 더 효과적으로 달성할 수 있다. 그리고 중소기업청이 정책적 목적으로 분류한 혁신형 중소기업(벤처기업, 이노비즈기업, 경영혁신형기업)은 비혁신형 중소기업보다 배당조정속도가 더 빠르다. 중소기업청에서 정책적 목적으로 분류한 혁신형 중소기업은 신용보증지원, 정책자금지원, 조세혜택, 공공입찰 우선권 부여 등과 같은 다양한 정책적 혜택으로 인해 재무적 제약을 적게 받기 때문에 배당지급을 더 신속하게 조정할 수 있다. 결론적으로, 한국거래소의 유가증권시장과 코스닥시장에 상장된 혁신형 중소기업은 비혁신형 중소기업보다 배당조정속도가 더 빠르고, 혁신형 중소기업 중에서도 재무적 비제약 기업은 재무적 제약 기업보다 배당조정 속도가 더 빠르다. 다시 말해, 중소기업 중에서도 R&D 집중도가 높은 혁신형 중소기업은 R&D 투자에 따른 미래의 성장성과 수익성을 담보로 하여 배당스무딩을 신속하게 할 수 있고, 혁신형 중소기업 중에서도 자본시장 접근성이 좋은 기업은 재무적 제약을 적게 받기 때문에 배당스무딩을 더 신속하게 할 수 있다. 따라서 중소기업 경영자는 R&D 집중도를 증가시키고 자본시장 접근성을 높여 재무적 제약을 회피함으로써 신속한 배당스무딩을 통해 장기적으로 안정적인 배당정책을 유지할 수 있다고 생각한다. 그리고 중소기업청이 정책적 목적으로 분류한 혁신형 중소기업(벤처기업, 이노비즈기업, 경영혁신형기업)의 경우에도 배당조정속도가 비혁신형 중소기업보다 더 빠르게 나왔다. 이러한 결과는 배당정책의 측면에서 중소기업청의 혁신형 중소기업 정책을 지지하는 실증적인 증거가 된다.

한국인 성인 안면두개골의 형태적 분류와 특징두부방사선 계측학적 연구 (CRANIOFACIAL MORPHOLOGIC PATTERNS RELAYED TO DIFFERENT FACIAL TYPES IN KOREAN ADULTS : A CEPHALOMETRIC ANALYSIS)

  • 조상원;최영철
    • 대한소아치과학회지
    • /
    • 제26권1호
    • /
    • pp.185-199
    • /
    • 1999
  • The purpose of the present study was to investigate craniofacial patterns in Korean male and female adults, and to compare morphologic differences between different facial types. In order to get configurational groupings, standardized lateral and P-A cephalograms of 174 Korean adults were measured and analyzed with seven angular, nineteen linear, four ratio, and two index measurements. Ward's minimum variance cluster analysis was employed to divide the sample into groups having similar craniofacial morphology, and thereafter, inductive statistics(t-test) was used to characterize morphologic differences of the divided groups. And also, Pearson correlation coefficients were calculated to assess correlation between the cranial dimensions and upper/lower anterior facial height(UAFH, LAFH) in each facial types for both male and female The results were as follows; 1. There existed sexual dimorphism in most of variables except SN-FH angle, palatal plane angle, facial axis angle, facial index, lower anterior facial height ratio and upper facial height ratio. 2. A brachycephalic headform ($0.84{\pm}0.05$) with leptoprosopic facial form ($0.92{\pm}0.05$) was appeared in male, and a mesocephalic headform ($0.86{\pm}0.06$) with leptoprosopic facial form ($0.92{\pm}0.04$) was exhibited in female. 3. Facial types in both male and female subjects were divided into two groups, Group A (mesoprosopic facial type) and Group B (leptoprosopic facial type). The morphologic differences between Group A and Group B were as follows: a. Cranial measurements including index, angular and linear measurements were not found to be different between Group A and Group B in both sexes. b. Increased UAFH, LAFH, and upper/lower anterior dental heights were exhibited in Group Bs of both male and female. c. In both male and female, ramus height and mandible length showed no difference between Group A and Group B. However, genial angle was found to be larger in Group B than Group A. Therefore, the morphologic differences between two groups in male and female were closely related to less favorable anatomic morphology of the mandible. 4. LAFH and UAFH showed no relationships with cranial dimensions in male and female.

  • PDF

엎드린 자세에서 고관절 신전 시 고관절 외회전 각도가 골반과 하지 근활성도에 미치는 영향 (Effect of Hip External Rotation Angle on Pelvis and Lower Limb Muscle Activity During Prone Hip Extension)

  • 오윤찬;신헌석;이충휘;전혜선;윤태림
    • 한국전문물리치료학회지
    • /
    • 제21권3호
    • /
    • pp.1-10
    • /
    • 2014
  • The aim of this study was to investigate the effect of hip external rotation angle on pelvis and lower limb muscle activity during prone hip extension. Sixteen healthy men were recruited for this study. Each subject performed an abdominal drawing-in maneuver (ADIM) in a prone position, and extended the dominant hip at three different hip external rotation angles ($0^{\circ}$, $20^{\circ}$, $40^{\circ}$) with a $30^{\circ}$ hip joint abduction. Activity of the gluteus maximus (G Max), gluteus medius (G Med), and hamstring (HAM) and the G Max/HAM and G Med/HAM ratios were determined with surface electromyography (EMG). The EMG signal was normalized to 100% maximum voluntary isometric contractions (MVICs) and expressed as %MVIC. Data were analyzed by one-way repeated analysis of variance (alpha level=.05) and the Bonferroni post hoc test. Significant differences in G Max and G Med muscle activity were noted among the three different hip external rotation angles. G Max muscle activity increased significantly at both $40^{\circ}$ (p=.006) and $20^{\circ}$ (p=.010) compared to a $0^{\circ}$ hip external rotation angle. G Med muscle activity increased significantly at $20^{\circ}$ (p=.013) compared to a $40^{\circ}$ hip external rotation angle. The G Max/HAM activity ratio increased significantly at both $40^{\circ}$ (p=.004) and $20^{\circ}$ (p=.014) compared to a $0^{\circ}$ hip external rotation angle. The G Med/HAM activity ratio increased significantly at $20^{\circ}$ (p=.013) compared to a $40^{\circ}$ hip external rotation angle. In conclusion, $40^{\circ}$ and $20^{\circ}$ hip external rotation angles are recommended to increase G Max activity, and $20^{\circ}$ hip external rotation is advocated to enhance G Med muscle activity during prone hip extension with ADIM and $30^{\circ}$ hip abduction in healthy subjects.

중성자 방사화분석에 의한 한국산 고고학적 유물의 특성화 연구 (I). 다변량 해석법에 의한 고전 (古錢) 의 분류 연구 (Characterization of Korean Archaeological Artifacts by Neutron Activation Analysis (I). Multivariate Classification of Korean Ancient Coins.)

  • 이철;권오천;강형태;이인종;김낙배
    • 대한화학회지
    • /
    • 제31권6호
    • /
    • pp.555-566
    • /
    • 1987
  • 조선조에 주조된 古錢 시료 50개를 입수하여 그 속에 함유된 9종의 원소(Sn, Fe, As, Ag, Co, Sb, Ir, Ru, Ni)는 중성자방사화분석에 의하고 3종 원소(Cu, Pb,Zn)는 원자흡수분광분석법에 의해 각각 정량하였다. 초기 청동화는 주성분인 Cu, Pb,Zn의 비가 90:4:3였고 말기 청동화는 7:2:0이었다. 황동화는 17세기에 비롯되었으며 그 주성분인 Cu, Pb,Zn의 조성은 7:1:1이었다. 이들 12종 원소의 분석데이타를 사용하여 원소 상호간의 상관관계를 상관메트릭스법으로 검토하였다. 그리고 주성분 분석법으로 각 시료의 농도 분포를 평면에 나타내었으며, 제조연대 및 제조관청이 같은 시료가 모이면 이들 시료를 SIMCA를 위한 참조 시료로 삼았다. SIMCA에 의해 8개군으로 분류되었으며 참조시료 및 시험시료가 어떤 군에 속하는지 또는 열외인지 연구 검토하였다.

  • PDF

유기성폐기물의 혐기성 소화에 의한 바이오가스 생산 기술 (Anaerobic digestion technology for biogas production using organic waste)

  • 김형건;이대성;장해남;정태학
    • 유기물자원화
    • /
    • 제18권3호
    • /
    • pp.50-59
    • /
    • 2010
  • 본 연구에서는 고농도 유기성 폐기물인 음폐수와 돈분뇨를 혐기성 소화조(KH-ABC)에서 병합처리하여 대체 에너지원인 바이오가스를 생산하는 바이오가스 Pilot Plant의 성능을 검증하고 평가하였다. 그리고, 혐기성 소화 공정의 독성물질에 대한 저해 여부 가능성 및 소화액의 액비 활용 가능성에 대하여 살펴보았다. 원료 투입량, 수리학적 체류시간, 원료 배합비율(음폐수와 돈분뇨의 혼합비율) 등 운전조건의 변화에 따른 유기물(VS) 분해율, 바이오가스 생산량 및 메탄농도 등을 분석한 결과 원료의 유기물부하가 증가($1.2{\sim}2.0kg-VS/m^3{\cdot}d$)함에 따라 투입 유기물 당 바이오가스 생산량은 $0.60{\sim}0.69m^3/kg-VS_{input}$로 증가하는 경향을 보였다. 특히 원료투입량 $6m^3$/일, 원료배합비율 음폐수:돈분뇨=4:6, 수리학적 체류시간(HRT) 25일의 조건에서 유기물 분해율 70%, 바이오가스 생산량 $220m^3$/일, 메탄농도 64%로 비교적 높은 성능을 나타냈다. 그리고, 소화액을 분석한 결과 혐기성 소화공정에 저해 작용을 유발하는 양이온 및 중금속 등의 독성물질은 기준농도 이하로 존재하였으며, 소화액(원료배합비율 음폐수:돈분뇨=3:7)은 액비 활용기준인 비료공정규격을 만족하였다.